NCT01824251: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. |
|
|
| Completed | 3 | 49 | Japan | NPB-01, Intravenous immunoglobulin | Nihon Pharmaceutical Co., Ltd | Chronic Inflammatory Demyelinating Polyneuropathy | 09/15 | 09/15 | | |